YS Biopharma (YS) Earnings Date, Estimates & Call Transcripts → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free YS Stock Alerts $0.80 -0.02 (-1.85%) (As of 04:00 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateJan. 22ConfirmedActual EPS (Jan. 22) -$0.16 Missed By -$0.16 Get YS Biopharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for YS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueYS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.YS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide YS Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ4 20241($0.08)($0.08)($0.08) 20241($0.08)($0.08)($0.08) Q1 20251($0.09)($0.09)($0.09) Q2 20251($0.08)($0.08)($0.08) Q3 20251($0.06)($0.06)($0.06) Q4 20251($0.02)($0.02)($0.02) FY 20254($0.25)($0.25) ($0.25)YS Earnings Date and InformationYS Biopharma last posted its quarterly earnings data on January 22nd, 2024. The reported ($0.16) earnings per share (EPS) for the quarter. The company earned $13.64 million during the quarter. YS Biopharma has generated $0.00 earnings per share over the last year. Earnings for YS Biopharma are expected to grow in the coming year, from ($0.24) to ($0.15) per share. Read More YS Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript1/22/2024Q2 2024-($0.16)($0.16)($0.16)-$13.64 million8/15/2023Q1 2024-($0.10)($0.10)($0.10)-$24.40 million11/14/2022Q3 2022-$0.22+$0.22$0.22--8/12/2022Q2 2022-$0.07+$0.07$0.07--5/13/2022Q1 2022-$0.28+$0.28$0.28--3/31/2022Q4 2021-$0.23+$0.23$0.23-- Get the Latest News and Ratings for YS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter. YS Biopharma Earnings - Frequently Asked Questions When did YS Biopharma announce their last quarterly earnings? YS Biopharma (NASDAQ:YS) last announced its quarterly earning data on Monday, January 22, 2024. Learn more on YS's earnings history. How much revenue does YS Biopharma generate each year? YS Biopharma (NASDAQ:YS) has a recorded annual revenue of $100 million. How much profit does YS Biopharma generate each year? YS Biopharma (NASDAQ:YS) has a recorded net income of -$21.17 million. YS has generated $0.00 earnings per share over the last four quarters. What is YS Biopharma's EPS forecast for next year? YS Biopharma's earnings are expected to grow from ($0.24) per share to ($0.15) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Spero Therapeutics Earnings Results Q32 Bio Earnings Results BioXcel Therapeutics Earnings Results Oncolytics Biotech Earnings Results Marinus Pharmaceuticals Earnings Results Affimed Earnings Results Cue Biopharma Earnings Results Chimerix Earnings Results PMV Pharmaceuticals Earnings Results Leap Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:YS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YS Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
